AzTrials
AzTrials

Iron Deficiency and/or AnemiaMM_RiceNCT02714075

Comparison of Iron Absorption From Extruded FePP-fortified Rice Containing Zinc, Citric Acid/Trisodium Citrate and EDTA

A study testing Ferric Pyrophosphate and Zinc Oxide, Ferric Pyrophosphate and Zinc Sulphate and Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium Citrate in people with Iron Deficiency and/or Anemia, run by Swiss Federal Institute of Technology at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Rice can only be fortified with ferric pyrophosphate (FePP), which is of low bioavailability in human subjects. Compounds such as citric acid/trisodium citrate (CA/TSC) or sodium ethylene-diamine tetraacetic-acid (EDTA) could serve as absorption enhancers. Read more about this study

Who is it for?
Ages 5 to 9 years
Conditions the study is for
Iron Deficiency and/or Anemia
What is being tested?
Ferric Pyrophosphate and Zinc Oxide, Ferric Pyrophosphate and Zinc Sulphate and Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium Citrate
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
2 sitesin 2 countries
Study dates
Apr 2016to Jun 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 9 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Iron deficient and/or anemic as per definition;
  • Read and signed informed consent form by the caregiver (or has been read out to the caregiver in case of illiteracy);
  • Absence of any metabolic-, gastrointestinal or chronic diseases.

Who cannot join

  • Severe underweight (Z-score weight-for-age <-3);
  • Severe wasting (Z-score weight-for-height<-3);
  • Chronic or acute illness or other conditions that in the opinion of the Principle Investigator (PI) or co-researchers would jeopardize the safety or rights of a participant in the trial or would render the participant unable to comply with the protocol;
  • Participants taking part in other studies requiring the drawing of blood;
  • Participants who will not be able to comply with the protocol (e.g. plan to move, planned absence, etc.);
  • Regular intake (>2 days) of iron-containing mineral and vitamin supplements within the last 2 months.

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Ghana1 site
  • University for Development Sciences

    Tamale, Northern Region, 1883

Other trials in Ghana

Switzerland1 site
  • Swiss Federal Institute of Technology (ETH)

    Zurich, Canton of Zurich, 8092

Other trials in Switzerland

About this study

Official title: Comparison of Iron Absorption From Extruded FePP-fortified Rice Containing Different Zinc Compounds, Citric Acid/Trisodium Citrate and Sodium EDTA

Rice can only be fortified with ferric pyrophosphate (FePP), which is of low bioavailability in human subjects. Compounds such as citric acid/trisodium citrate (CA/TSC) or sodium ethylene-diamine tetraacetic-acid (EDTA) could serve as absorption enhancers. Recent findings from single meal studies indicate CA/TSC to have an enhancing effect on iron absorption from FePP-fortified rice. In contrast, ZnO has been suggested to have detrimental effects. Furthermore, in vitro findings suggest an increased iron solubility from iron and EDTA-co-fortified rice - but the bioavailability in humans remains to be investigated. These effects should thus be investigated in 'real-life' conditions, when fortified rice is implemented in a complete diet administered throughout several days in a target population for a rice fortification program.

Objective: To assess iron absorption from the diet from different iron fortified rice formulations in iron deficient anaemic children.

The investigators aim to conduct an iron absorption study in 30 Ghanaian school-age children investigating different fortification approaches in a multiple meal randomized, cross over study.

Read the detailed description

Iron of differing molecular weights (54Fe, 56Fe, 57Fe, 58Fe) and other nutrients and additives will be extruded into rice kernels, these kernels will be blended with regular unfortified rice and administered to the study participants.

Recruitment of study participants will be through a local investigator in close collaboration with the Ghanaian school authorities. Before starting the study, 6 children will be asked to participate in a pilot testing, where they will be administered 2 portions of rice (50 g dry weight) with a vegetable sauce with a four hours delay in between the meals. This is to allow the investigators to define, the optimal portion size, that will be used throughout the study. For their participation, the children will receive a small symbolic gift. The investigators envisage screening approximately 60 children living in Tamale and surrounding rural areas at least one week before study start. Recruitment of participants will be done until reaching a number of 30 eligible participants. Participant's caretakers will be explained the study procedures and need to sign a consent form before the participant is exposed to any study procedure. Participants at screening will be assigned a unique study identification (running number and participant's initials), which they will keep if included in the study. All data will be kept confidential. The medical history, dietary intake data and data concerning socioeconomic status will be assessed using questionnaires, body temperature, height and weight will be measured and z-scores (weight for age) will be calculated. A blood sample will be collected from each participant for the initial determination of iron status, detection of parasitic infections (including measurements of hemoglobin (Hb), serum ferritin (SF), soluble transferrin receptor (sTfR), Zinc protoporphyrin to heme ratio (ZPP), C-reactive protein (CRP), Alpha acid glycoprotein, and malaria parasitemia. All screened participants will receive an appropriate dose of an anthelmintic free of charge, unless they had received an according treatment within the last two months. Based on the information obtained from screening, in-/ exclusion criteria will be checked and participant's eligibility will be judged accordingly. Thirty iron deficient and/or anemic children (hereafter called participants) will be included in the absorption study. For the initial determination of the iron status and infection detection, the children will receive a symbolic gift from the investigators. There will be no monetary compensation for participation; however, the children or their caregivers will receive a symbolic gift for completion of the study. Potential transport costs for the children and their caregivers will be covered by the project.

The whole study duration will be eleven weeks (excluding screening and pilot testing). Participants will donate one blood sample at screening and two blood samples during the remaining study period. Between Monday and Friday, the participants will receive two meals per day, one in the morning (first meal) and one at noon (second meal). One type of test meal will always be administered throughout five consecutive days. In total each participant will receive 60 rice meals each meal consisting of approximately 50 g regular unfortified rice, 0.5 g extruded fortified rice, 30 g sauce and 250 ml water. The definite rice amount administered will be decided upon after a pilot investigation. The order of the test meals given in each week will be partially randomized. Thus, if test meals A, B or C will be given throughout 1 week between weeks 1 and 3, test meals D, E and R will be given between weeks 6 and 8. Meals containing iron with the same molecular weight (58 Fe, 57Fe and 54Fe) have to be administered at least 16 days apart from each other, which is the only restriction for randomization. The participants are not allowed to eat after 8 PM and to drink after 12 AM on the day before each study visit, between the meals and for three hours after they finished their second meal, unless they are given snacks by the investigators and are explicitly allowed to eat those. Each meal administration will take approximately 25 minutes. This procedure will be followed for six weeks, with a two weeks break between weeks 3 and 6 (no dietary restrictions within the break-period).

The test meals will be based on 50 g regular unfortified rice and 0.5 g extruded fortified rice (dry weight). The meals will be administered with one of two traditional sauces, with a low (sauce A) or moderate (sauce B) phytic acid (PA) content. Sauce A will be based on tomatoes and onions, sauce B will be based on cowpeas. The rice meals will be prepared individually for each subject, the sauce will be prepared in bulk before the study start. All meals will be served with 250 ml water. The test meals are designed to match ~2/3 of the average dietary requirements in that age-group. In case the rice meals do not provide enough energy (~700 - 900 kcal), the investigators will administer a standardized snack to be consumed during the fasting periods.

Being tested
Ferric Pyrophosphate and Zinc Oxide, Ferric Pyrophosphate and Zinc Sulphate, Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium Citrate, Ferric Pyrophosphate, ZnSO4, CA/TSC, Ferric Pyrophosphate, ZnO, CA, EDTA
Medical subject headings
Anemia, Iron-Deficiency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ferric Pyrophosphate and Zinc OxideOther

    Extruded rice fortified with Ferric Pyrophosphate, Zinc Oxide (ZnO) and micronutrients

  • Ferric Pyrophosphate and Zinc SulphateOther

    Extruded rice fortified with Ferric Pyrophosphate, Zinc Sulphate (ZnSO4) and micronutrients

  • Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium CitrateOther

    Extruded rice fortified with Ferric Pyrophosphate, Zinc Oxide (ZnO), Citric Acid (CA) and Trisodium Citrate (TSC) and micronutrients

  • Ferric Pyrophosphate, ZnSO4, CA/TSCOther

    Extruded rice fortified with Ferric Pyrophosphate, ZnSO4, CA/TSC and micronutrients

  • Ferric Pyrophosphate, ZnO, CA, EDTAOther

    Extruded rice fortified with Ferric Pyrophosphate, ZnO, CA, EDTA and micronutrients

  • Ferrous SulphateOther

    Extruded rice fortified with micronutrients, Ferrous Sulphate solution will be added at consumption

Study groups in NCT02714075
Study groupRoleWhat they receive
Iron fortified riceExperimentalAdministration of iron fortified rice to all subjects; subjects will act as their own controls and each subject will receive all foreseen treatments/interventions.
Receives: Other: Ferric Pyrophosphate and Zinc Oxide; Other: Ferric Pyrophosphate and Zinc Sulphate; Other: Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium Citrate; Other: Ferric Pyrophosphate, ZnSO4, CA/TSC; Other: Ferric Pyrophosphate, ZnO, CA, EDTA; Other: Ferrous Sulphate

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fractional iron absorption

    Change from baseline in the isotopic ratio of iron in blood at week 6 and 11after the administration of test meal including iron isotopes.

    Measured: baseline, 6 weeks, 11 weeks

Secondary outcomes (6)
  1. Hemoglobin

    Measurements from blood will be given in mg/l.

    Measured: Baseline, Week 6, Week 11

  2. Plasma Ferritin

    Measurements from blood will be given in mg/l.

    Measured: Baseline, Week 6, Week 11

  3. C-reactive protein

    Measurements from blood will be given in mg/l.

    Measured: Baseline, Week 6, Week 11

  4. Zinc protoporphyrin measurement as zinc to heme ratio

    Measured: Baseline, Week 6, Week 11

  5. Soluble Transferrin receptor in mg/l

    Measured: Baseline, Week 6, Week 11

  6. Alpha amino glycoprotein in mg/l

    Measured: Baseline, Week 6, Week 11

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2016 (estimated)
  2. Study startApr 2016
  3. Primary completionJun 2016
  4. Study completionJun 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02714075
Sponsor's protocol ID
MM_Rice
Acronym
MM_Rice
Status last verified
Dec 2016
First submitted
10 Mar 2016
Last updated
7 Dec 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Ferric Pyrophosphate and Zinc Oxide, Ferric Pyrophosphate and Zinc Sulphate and Ferric Pyrophosphate, ZnO, Citric Acid and Trisodium Citrate in people with Iron Deficiency and/or Anemia, run by Swiss Federal Institute of Technology at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Dec 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Ghana, Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fractional iron absorption (time frame: baseline, 6 weeks, 11 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Dec 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in